Results 141 to 150 of about 7,411 (220)

Glabridin and gymnemic acid alleviates choroid structural change and choriocapillaris impairment in diabetic rat's eyes. [PDF]

World J Diabetes
Matsathit U, Komolkriengkrai M, Khimmaktong W.   +2 more
europepmc   +1 more source

Cardiovascular Events in Individuals Treated With Sulfonylureas or Dipeptidyl Peptidase 4 Inhibitors.

JAMA Netw Open
Turchin A, Petito LC, Hegermiller E, Carnahan R, DeVries A, Goel S, Lansang MC, McDonnell ME, Nair V, Priest E, Willey VJ, Kaul AF, Hernán MA.   +12 more
europepmc   +1 more source

Medications Associated with Increased Risk of Hypoglycemia in Older Adults on Sulfonylureas: A High-Throughput Case-Crossover-Based Screening Study. [PDF]

Drug Saf
Bea S, Patorno E, Hahn G, Paik JM, Wexler DJ, Bykov K.   +5 more
europepmc   +1 more source

FORMULATION AND EVALUATION OF FLOATING BIOADHESIVE TABLET OF GLYBURIDE FOR DIABETES

Ayushi Pawar, Anu Hardenia
openalex   +1 more source

Monogenic Familial Neonatal Diabetes in Preterm Infant With ABCC8 Gene Mutation: Transition to Oral Sulfonylurea Therapy. [PDF]

J Pediatr Pharmacol Ther
Behre E, Donnell SS, Larsen N, Mora G, Patra K.   +4 more
europepmc   +1 more source

Targeting the NLRP3 inflammasome for inflammatory disease therapy. [PDF]

Trends Pharmacol Sci
Cabral JE, Wu A, Zhou H, Pham MA, Lin S, McNulty R.   +5 more
europepmc   +1 more source

Inhibition of prolyl-tRNA synthetase and efflux pumps as a dual-targeting strategy against multidrug-resistant bacteria. [PDF]

J Enzyme Inhib Med Chem
Tambascia C, Silva JC, Dos Reis BC, Camilo CFS, Tairum Junior CA, Hancio T, Correia VG, Pilli RA, de Godoy AS, Laleu B, Sforça ML, Rocco SA, Benedetti CE, Mercaldi GF.   +13 more
europepmc   +1 more source

Sulfonylurea drugs for people with severe hemispheric ischemic stroke. [PDF]

Cochrane Database Syst Rev
Fan L, Xu J, Wang T, Yang K, Bai X, Yang W.   +5 more
europepmc   +1 more source

Glipizide and glyburide.

North Carolina medical journal, 1986
openaire   +1 more source

MicroRNAs modulated by DPP-4 inhibitor and bedtime NPH insulin therapy in individuals with type 2 diabetes. [PDF]

Front Endocrinol (Lausanne)
Santos AS, Bando SY, Correa Giannella MLC, da Silva MER.   +3 more
europepmc   +1 more source